DICLOFENAC
Hand-foot Syndrome
Affiliated Hospital of Qinghai UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Hand-foot Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Mecobalamin Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 3 | B |
Same molecule, other indications
DICLOFENAC is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →